Oral Presentation Australian and New Zealand Society for Geriatric Medicine Annual Scientific Meeting 2025

The BIO-VAC Study: A Prospective Observational Study of Burden in Older Persons of Vascular Access and Cannulation (120106)

Danielle Ní Chróinín 1 2 , Lorenza Harrowell 3 4 , Evan Alexandrou 3 5 , Steve Frost 3 4 6
  1. Geriatric Medicine, Liverpool Hospital, Liverpool, NSW, Australia
  2. UNSW Sydney, South Western Sydney Clinical School, Liverpool, NSW, Australia
  3. Liverpool Hospital, Liverpool, NSW, Australia
  4. School of Nursing, University of Wollongong, Wollongong, NSW, Australia
  5. Western Sydney University, Liverpool, NSW, Australia
  6. South Western Sydney Nursing and Midwifery Research Alliance, University of Wollongong , Wollongong , NSW, Australia

Aims: To describe the use and outcomes of Vascular Access Devices (VADs) in older patients.

Methods: Prospective observational study of patients admitted under Geriatric Medicine and requiring a VAD (9 month period), evaluating cannulation sites, VAD-administered therapies, documentation, and complications.

Results: Amongst 215 patients- mean age 82.8 (SD 7.7), 60% (128) female, 26% living with dementia- 88% (189) had peripheral intravenous cannula (PIVC) at enrollment (80.9% 1 PIVC; 2 long, 187 short), all inserted in the Emergency Department. Commonest reasons for PIVC included IV medication (51%; 97/189) and blood-taking (50%). A subsequent 26 additional cannulae were inserted (outside ED) and eligible for inclusion.

Overall, 54% (117/215) had one PIVC and 13% ≥3 PIVCs during admission. Overall, 65% (123/189) existing cannulas failed within first 24 hours, with 56.4% of failed cannulas idle, and 44% suffering complications; all bar one had been blind insertions.

Failed PIVCs were commonly in antecubital fossa (51%) or hand/lower forearm (44%); 51% (63/123) of those with failed PIVC required a second PIVC to complete treatment. Absolute risk of failed cannulation increased from ~40% day 1 to 80% day 7. Amongst failed cannulae, median number of cannulation attempts per patient was 7 (IQR 2.75-11). Median delay to second attempt was 150 minutes (9-368). Poor documentation of phlebitis scores and inappropriate device selection further contributed to burden.

Conclusions: The burden of PIVC failure highlights the need for proactive monitoring, timely intervention, and collaboration with vascular access teams, to improve patient care. Cost analysis (planned) will also be helpful.